Meta-analysis of 43 studies (n=388,447): pooled lifetime prevalence of CBD use was 28.9% in North America and 12.8% in Europe; daily use was 6.4% and 2.1%. Past-year use differed by clinical versus community samples.
Meta-analysisn = 388,447
Weidberg et al. The prevalence of cannabidiol (CBD) use in North America and Europe: A meta-analysis